Page 5 - Formp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Brokerages expect Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) to announce sales of $700,000.00 for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Oramed Pharmaceuticals’ earnings. Oramed Pharmaceuticals posted sales of $670,000.00 in the same quarter last year, which would indicate a positive year over year growth rate of […]

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) Director Kevin Rakin sold 10,000 shares of the firm’s stock in a transaction on Monday, March 21st. The shares were sold at an average price of $9.41, for a total transaction of $94,100.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can […]

Brokerages predict that Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) will report earnings of ($0.19) per share for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Oramed Pharmaceuticals’ earnings. The highest EPS estimate is ($0.15) and the lowest is ($0.23). Oramed Pharmaceuticals reported earnings of ($0.17) per share during […]

Wall Street analysts forecast that Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) will announce $700,000.00 in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Oramed Pharmaceuticals’ earnings. Oramed Pharmaceuticals posted sales of $670,000.00 in the same quarter last year, which suggests a positive year over year growth rate of 4.5%. […]

NEW YORK (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $5.6...